Cancer Talk

News

Roswell Park’s OmniSeq Target Panel Discussion Dec. 2 to Inform Public About Groundbreaking Diagnostic Test

n July, Roswell Park Comprehensive Cancere Center received approval from the New York State Department of Health to begin genomic testing of cancer patients using an advanced molecular diagnostic laboratory test developed by the Roswell Park Center for Personalized Medicine. Now, the same experts who led the development and clinical implementation of that groundbreaking tool, OmniSeq Target™, are conducting a public forum to help families affected by cancer understand how this new approach is changing the face of cancer diagnosis and treatment.
News

New Roswell Park Endoscopy Center is First of its Kind in Region

At a ribbon-cutting ceremony today, Roswell Park Comprehensive Cancer Center unveiled a new Endoscopy Center, a multipurpose clinical space that brings together advanced endoscopy and interventional pulmonology services into one state-of-the-art facility. The new center, designed for optimal patient safety and comfort, was built to meet increasing demand for minimally invasive endoscopic procedures used for diagnosis, staging and treatment of malignant and nonmalignant gastrointestinal and pulmonary conditions.

News

Cleveland BioLabs, Roswell Park Publish Studies on Curaxin CBL0137 in Preclinical Models of Pancreatic Cancer

Cleveland BioLabs, Inc. and Roswell Park Cancer Institute today announced the publication of studies in Oncotarget describing the preclinical efficacy of Curaxin CBL0137 as a single agent and in combination with the current standard-of-care therapy, gemcitabine, against different models of pancreatic ductal adenocarcinoma (PDA), including models of gemcitabine-resistant tumors. The reported studies were conducted by scientists at Roswell Park, SUNY Downstate Medical Center and Buffalo Biolabs, LLC.
News

Video-Assisted Thoracoscopic Surgery Technique for Pneumonectomy Shown to Be Safe

In the largest series of its kind to date, researchers at Roswell Park Cancer Institute (RPCI) have shown that performing thoracoscopic pneumonectomy, removal of the entire lung through a minimally invasive endoscopic approach, at a high-volume center appears to be safe and may provide pain and survival advantages in the long term.
News

Dr. Candace Johnson Named Cancer Center Director at Roswell Park Comprehensive Cancer Center

Candace S. Johnson, PhD, has been promoted to Cancer Center Director at Roswell Park Comprehensive Cancer Center, the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. In this new role with the Institute, she will manage the Institute's Cancer Center Support Grant from the NCI as Principal Investigator and will oversee faculty recruitment and allocation of resources including space, personnel and institutional funds.